Education
About Us
Working with TipRanks
Follow Us
BBEU - ETF AI Analysis
Top Page
JPMorgan BetaBuilders Europe ETF (BBEU)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as ASML Holding and Nestlé, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF has a very low expense ratio compared to industry averages, making it a cost-effective choice for investors.
Broad Geographic Exposure
The fund is diversified across multiple European countries, reducing reliance on any single economy.
Negative Factors
Underperforming Holdings
Some top holdings, like SAP and LVMH, have lagged in year-to-date performance, which could weigh on future returns.
Sector Concentration in Financials
The ETF has significant exposure to the financial sector, which could make it sensitive to industry-specific risks.
Limited U.S. Exposure
The fund has minimal exposure to U.S. companies, which may limit its ability to benefit from growth in the world's largest economy.
BBEU vs. SPDR S&P 500 ETF (SPY)
AUM8.55B
RegionEurope
Expense Ratio0.09%
Beta0.65
IssuerJPMorgan
Inception DateJun 15, 2018
Dividend Yield3.28%
Asset ClassEquity
Index TrackedMorningstar Developed Europe Target Market Exposure Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume433,460
30 Day Avg. Volume1,403,795
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
80.36Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering376
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BBEU Summary
The JPMorgan BetaBuilders Europe ETF (BBEU) is a fund that lets investors access a wide range of companies across Europe by tracking the Morningstar Developed Europe Target Market Exposure Index. It includes businesses from various sectors like finance, healthcare, and technology, with well-known companies such as Nestlé and AstraZeneca among its top holdings. This ETF is a great option for those looking to diversify their portfolio and benefit from the growth potential of European economies. However, new investors should be aware that its performance can fluctuate with the overall European market, which may be impacted by economic or political changes in the region.
How much will it cost me?The JPMorgan BetaBuilders Europe ETF (BBEU) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks a broad European equity index, which typically involves lower costs compared to actively managed funds.
What would affect this ETF?The JPMorgan BetaBuilders Europe ETF (BBEU) could benefit from economic recovery in Europe, increased consumer spending, and advancements in technology and healthcare, as these sectors are heavily represented in its holdings. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in Europe could negatively impact financial and industrial sectors, which are significant components of this ETF. Investors should also monitor currency fluctuations and global economic conditions, as these factors can influence the performance of European markets.
BBEU Top 10 Holdings
The JPMorgan BetaBuilders Europe ETF (BBEU) leans heavily into financials and industrials, with names like HSBC and Siemens shaping its performance. HSBC is rising steadily, buoyed by strong earnings and strategic growth, while Siemens has been lagging, weighed down by mixed market sentiment. Healthcare giants like Roche and AstraZeneca are providing a steady lift, thanks to robust pipelines and solid profitability. Meanwhile, SAP’s bearish momentum is holding the fund back, as the tech sector faces valuation concerns. Overall, the ETF offers broad exposure to developed Europe, with a tilt toward stability over high-flying growth stories.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.43% | $292.37M | €361.36B | 38.64% | 76 Outperform | |
| AstraZeneca | 2.22% | $188.86M | £209.51B | 28.65% | 80 Outperform | |
| Roche Holding AG | 2.17% | $184.81M | CHF257.44B | 37.41% | 73 Outperform | |
| HSBC Holdings | 2.00% | $170.43M | HK$1.97T | 46.18% | 80 Outperform | |
| SAP SE | 1.98% | $168.35M | €246.20B | -12.66% | 66 Neutral | |
| Nestlé SA | 1.95% | $165.88M | CHF196.65B | 15.97% | 71 Outperform | |
| Novartis AG | 1.90% | $161.70M | CHF200.64B | 20.35% | 80 Outperform | |
| Shell (UK) | 1.65% | $141.00M | £154.81B | 8.06% | 73 Outperform | |
| Siemens | 1.57% | $133.50M | €181.39B | 21.30% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.46% | $124.53M | €307.60B | -3.60% | 78 Outperform |
BBEU Technical Analysis
Positive
―
Price Trends
70.64
Positive
69.39
Positive
66.53
Positive
Market Momentum
0.53
Negative
60.13
Neutral
86.29
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 70.79, equal to the 50-day MA of 70.64, and equal to the 200-day MA of 66.53, indicating a bullish trend. The MACD of 0.53 indicates Negative momentum. The RSI at 60.13 is Neutral, neither overbought nor oversold. The STOCH value of 86.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BBEU.
BBEU Peer Comparison
Comparison Results
Performance Comparison
BBEU
JPMorgan BetaBuilders Europe ETF
72.25
16.31
29.16%
EZU
iShares MSCI Eurozone ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
FEZ
SPDR EURO STOXX 50 ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
IEV
iShares Europe ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents